EMEA-002479-PIP01-18-M02 - paediatric investigation plan
narsoplimab
PIPHuman
Estonian is available via eTranslation, the European Commission's machine translation service.
Translate to Estonian | Important information about machine translation
Key facts
- Active substance
- narsoplimab
- Therapeutic area
- Blood and lymphatic system disorders
- Decision number
- P/0297/2024
- PIP number
- EMEA-002479-PIP01-18-M02
- Pharmaceutical form(s)
- Solution for injection/infusion
- Condition(s) / indication(s)
- Treatment in haematopoietic stem cell transplantation
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Omeros Ireland Limited
E-mail: regulatory@omeros.com
Tel: +1 206-676-5000- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date
- Compliance check done
- Ei